@misc{indiciaed49f41d87fa4, title = {Discovery of an orally available potent ER aminopeptidase 1 (ERAP1) inhibitor that enhances anti-tumor responses and limits inflammatory autoimmunity in vivo.}, author = {Tinworth, C. P. and Wojno-Picon, J. and Adam, M. and Gade, S. and Hancock, A. P. and Hirst, D. J. and Hutchinson, J. P. and Kitchen, S. J. and Koumantou, D. and Lea, J. D. and Lehmann, S. and Liddle, J. and Lonsdale, R. and Neu, M. and Nickels, L. and Phillipou, A. and Rowedder, J. E. and Rowland, P. and Schneck, J. L. and Scott-Stevens, P. T. and Sheehan, H. and Steidel, M. and Tayler, C. L. and Temponeras, I. and Thang, K. and Tough, D. F. and Vitulli, G. and Wall, I. D. and Young, R. J. and Zinn, N. and Peace, S. and Stratikos, E.}, year = {2025}, doi = {10.1101/2025.11.17.686761}, url = {https://www.biorxiv.org/content/10.1101/2025.11.17.686761v1}, note = {Source identifier: 10.1101/2025.11.17.686761} }